Evaluation of Soluble Fibrin in Thrombosis Exclusion

CompletedOBSERVATIONAL
Enrollment

863

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

July 31, 2018

Conditions
Pulmonary Embolism (PE)Deep Vein Thrombosis (DVT)
Interventions
OTHER

Soluble Fibrin

Evaluating the diagnostic performances of the assay in terms of sensitivity, specificity, negative and positive predictive values; from calculation of the area under the curve in comparison with the D-dimers.

Trial Locations (1)

92701

Internal Medecine Unit - Adults Pole and Hematology Laboratory Hôpital Louis Mourier (AP-HP), Colombes

Sponsors
All Listed Sponsors
collaborator

Hôpital Louis Mourier

OTHER

collaborator

Hopital Lariboisière

OTHER

lead

Diagnostica Stago R&D

INDUSTRY

NCT02523937 - Evaluation of Soluble Fibrin in Thrombosis Exclusion | Biotech Hunter | Biotech Hunter